Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia
ATM and TP53 mutations are associated with poor prognosis in chronic lymphocytic leukaemia (CLL). Here the authors generate mouse models of Tp53- and Atm-defective CLL mimicking the high-risk form of human disease and show that Atm-deficient CLL is sensitive to PARP1 inhibition.
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/93c8b6674f2b4c01a38589c9951b35af |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:93c8b6674f2b4c01a38589c9951b35af |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:93c8b6674f2b4c01a38589c9951b35af2021-12-02T13:24:23ZTwo mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia10.1038/s41467-017-00210-62041-1723https://doaj.org/article/93c8b6674f2b4c01a38589c9951b35af2017-07-01T00:00:00Zhttps://doi.org/10.1038/s41467-017-00210-6https://doaj.org/toc/2041-1723ATM and TP53 mutations are associated with poor prognosis in chronic lymphocytic leukaemia (CLL). Here the authors generate mouse models of Tp53- and Atm-defective CLL mimicking the high-risk form of human disease and show that Atm-deficient CLL is sensitive to PARP1 inhibition.Gero KnittelTim RehkämperDarya KorovkinaPaul LiedgensChristian FritzAlessandro TorgovnickYussor Al-BaldawiMona Al-MaarriYupeng CunOleg FedorchenkoArina RiabinskaFilippo BeleggiaPhuong-Hien NguyenF. Thomas WunderlichMonika OrtmannManuel Montesinos-RongenEugen TauschStephan StilgenbauerLukas P. FrenzelMarco HerlingCarmen HerlingJasmin BahloMichael HallekMartin PeiferReinhard BuettnerThorsten PersigehlH. Christian ReinhardtNature PortfolioarticleScienceQENNature Communications, Vol 8, Iss 1, Pp 1-13 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Gero Knittel Tim Rehkämper Darya Korovkina Paul Liedgens Christian Fritz Alessandro Torgovnick Yussor Al-Baldawi Mona Al-Maarri Yupeng Cun Oleg Fedorchenko Arina Riabinska Filippo Beleggia Phuong-Hien Nguyen F. Thomas Wunderlich Monika Ortmann Manuel Montesinos-Rongen Eugen Tausch Stephan Stilgenbauer Lukas P. Frenzel Marco Herling Carmen Herling Jasmin Bahlo Michael Hallek Martin Peifer Reinhard Buettner Thorsten Persigehl H. Christian Reinhardt Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia |
description |
ATM and TP53 mutations are associated with poor prognosis in chronic lymphocytic leukaemia (CLL). Here the authors generate mouse models of Tp53- and Atm-defective CLL mimicking the high-risk form of human disease and show that Atm-deficient CLL is sensitive to PARP1 inhibition. |
format |
article |
author |
Gero Knittel Tim Rehkämper Darya Korovkina Paul Liedgens Christian Fritz Alessandro Torgovnick Yussor Al-Baldawi Mona Al-Maarri Yupeng Cun Oleg Fedorchenko Arina Riabinska Filippo Beleggia Phuong-Hien Nguyen F. Thomas Wunderlich Monika Ortmann Manuel Montesinos-Rongen Eugen Tausch Stephan Stilgenbauer Lukas P. Frenzel Marco Herling Carmen Herling Jasmin Bahlo Michael Hallek Martin Peifer Reinhard Buettner Thorsten Persigehl H. Christian Reinhardt |
author_facet |
Gero Knittel Tim Rehkämper Darya Korovkina Paul Liedgens Christian Fritz Alessandro Torgovnick Yussor Al-Baldawi Mona Al-Maarri Yupeng Cun Oleg Fedorchenko Arina Riabinska Filippo Beleggia Phuong-Hien Nguyen F. Thomas Wunderlich Monika Ortmann Manuel Montesinos-Rongen Eugen Tausch Stephan Stilgenbauer Lukas P. Frenzel Marco Herling Carmen Herling Jasmin Bahlo Michael Hallek Martin Peifer Reinhard Buettner Thorsten Persigehl H. Christian Reinhardt |
author_sort |
Gero Knittel |
title |
Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia |
title_short |
Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia |
title_full |
Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia |
title_fullStr |
Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia |
title_full_unstemmed |
Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia |
title_sort |
two mouse models reveal an actionable parp1 dependence in aggressive chronic lymphocytic leukemia |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/93c8b6674f2b4c01a38589c9951b35af |
work_keys_str_mv |
AT geroknittel twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia AT timrehkamper twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia AT daryakorovkina twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia AT paulliedgens twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia AT christianfritz twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia AT alessandrotorgovnick twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia AT yussoralbaldawi twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia AT monaalmaarri twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia AT yupengcun twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia AT olegfedorchenko twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia AT arinariabinska twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia AT filippobeleggia twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia AT phuonghiennguyen twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia AT fthomaswunderlich twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia AT monikaortmann twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia AT manuelmontesinosrongen twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia AT eugentausch twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia AT stephanstilgenbauer twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia AT lukaspfrenzel twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia AT marcoherling twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia AT carmenherling twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia AT jasminbahlo twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia AT michaelhallek twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia AT martinpeifer twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia AT reinhardbuettner twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia AT thorstenpersigehl twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia AT hchristianreinhardt twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia |
_version_ |
1718393107474546688 |